BMY: Bristol-Myers Squibb Company Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 119,702.99
Enterprise Value ($M) 161,659.99
Book Value ($M) 17,200.00
Book Value / Share 8.48
Price / Book 6.96
NCAV ($M) -48,395.00
NCAV / Share -23.86
Price / NCAV -2.47

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.08
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 1.09
Current Ratio 1.24

Balance Sheet (mrq) ($M)
Current Assets 28,075.00
Assets 93,670.00
Liabilities 76,470.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.74 -2.35
01-25 13G/A BlackRock Inc. 8.30 -2.68

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-13 1,425,659 8,557,319 16.66
2024-11-12 1,980,317 11,791,463 16.79
2024-11-11 3,390,614 23,137,728 14.65
2024-11-08 994,293 7,592,491 13.10

(click for more detail)

Similar Companies
ANVS – Annovis Bio, Inc. BHC – Bausch Health Companies Inc.
BHVN – Biohaven Ltd. CTLT – Catalent, Inc.
EBS – Emergent BioSolutions Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Bristol-Myers Squibb Company